• Sunday, Feb 28, 2021
  • Last Update : 09:49 am

WHO chief: Covid-19 testing still vital even as vaccines roll out

  • Published at 12:43 pm November 28th, 2020
Covid-19 vaccine
File photo: A booth, displaying a Covid-19 vaccine candidate from Sinovac Biotech Ltd, is seen at the 2020 China International Fair for Trade in Services, in Beijing on September 4, 2020 Reuters

Countries with decreasing Covid-19 numbers should not let their guard down 

Tedros Adhanom Gheybreyesus, the head of the World Health Organization (WHO) on Friday said testing will still be a critical tool against Covid-19, even as vaccines are deployed against the disease.

The WHO chief also emphasized on how testing has been common among countries which have worked to control the virus, during his regular briefing on the crisis, reports UN news.

“As vaccines are rolled out, testing will continue to play a vital role”, he said.

“Initially, health workers, older people and other at-risk groups will be prioritised for vaccination. That will still leave the virus with a lot of room to move, and testing will remain a vital tool for controlling the pandemic.”

However, Tedros stressed that though vital, testing is only part of the strategy against Covid-19.

“Testing is the spotlight that shows where the virus is. Investments in testing must be matched by investments in isolation facilities, clinical care, protecting health workers, contact tracing, cluster investigation and supported quarantine," he stated.

More evaluation needed

Meanwhile, WHO said more information is needed concerning the vaccine developed by the pharmaceutical company AstraZeneca and Oxford University.

The partners announced this week that clinical trials showed a regimen consisting of one half-dose of the vaccine, followed by a full dose a month later, was more effective than two full doses.

Dr Katherine O’Brien, director of Immunization, Vaccines and Biologicals at WHO, underlined the need for further evaluation as the data were reported in a press release.

“I think what we can emphasize, though, is that from what we understand about the press release, there is certainly something interesting that has been observed. But there are many reasons that could underlie the differences that were observed,” she said.

WHO’s Chief Scientist, Dr. Soumya Swaminatha, pointed out that less than 3,000 people were given the lower-dose regimen, according to the press release, all of whom were 55 years old or younger. 

She added that the other group consisted of more than 8,000 people of varying ages, thus making it very hard to compare the two, while overall, their numbers were too small to come to any definitive conclusions.

“It would be speculation at this point,” Dr Swaminathan told reporters.

She said AstraZeneca has informed WHO that it intends to run a full trial of the lower-dose regimen.

Lessons from Ebola

Global experience with storage and distribution of the Ebola vaccine could inform delivery of any potential inoculation against Covid-19 once developed, according to WHO.

“There is demonstrated experience of delivering ultra-cold chain vaccines, even in some of the most difficult and remote areas,” said Dr. O’Brien.  “But that has also taken enormous resources to do that.”

The WHO official was responding to a journalist’s question concerning the experimental vaccine developed by pharmaceutical companies Pfizer and BioNTech, which was recently submitted to authorities in the United States for emergency approval.

The vaccine, which has shown a more than 90% efficacy rate, requires very cold storage of -70°C or below, prompting concerns about potential distribution in African countries.

No one vaccine is enough

“We do have experience in a number of countries, specifically in Africa, being able to deploy a vaccine with that ultra-cold chain requirement,” said Dr O’Brien, referring to the Merck Ebola vaccine used in outbreaks in the Democratic Republic of the Congo.

“So, as we anticipate the use of the Pfizer vaccine, the intention is certainly to be able to use it along with other vaccines because no one vaccine is going to have adequate supply, nor will any one vaccine necessarily have suitable operational characteristics to meet all of the needs.”

Dr O’Brien added that Pfizer has developed a special “shipper” which can maintain the vaccine’s temperature for up to 10 to 15 days.

Furthermore, the vaccine can be stored at refrigerated temperatures for five days, she continued, while portable freezers that do not run on electricity, and even dry ice, also can be used.

Innovate for delivery

As ultra-cold chain logistics are not in place everywhere, including in high-income nations, Dr O’Brien suggested that countries will have to “innovate” around systems for delivering Covid-19 vaccines that have this requirement.  

One approach could be to use them for immunizing certain segments of the population.

She cited health professionals as an example, because they work in facilities where immunization would take place and where it would be easier to install the ultra-cold chain freezers. 

Move your body

Although the pandemic has imposed many restrictions on our lives, there is no excuse to sit on the couch, WHO affirmed on Friday, announcing new guidelines on physical activity and sedentary behaviour, published this week.

Exercise is essential for physical and mental health throughout life, the agency said, but one in four adults, and four in five adolescents, do not move enough.

The guidelines recommend between 150 and 300 minutes of moderate to vigorous activity per week for adults, and an average of 60 minutes per day for children and adolescents.

Countries should not let their guard down 

Countries with decreasing Covid-19 numbers still need to stay "vigilant," a World Health Organization (WHO) official said Friday.

"Even as case numbers are coming down, all countries need to remain vigilant. You've heard of this before, but we really need to emphasize it again. Do not let your guard down," Maria Van Kerkhove, technical lead for WHO's Health Emergencies Program, said during a virtual briefing, reports Xinhua.

"It's good to see the measures taking effect and transmission going down. But it's not time to let up. It's time to even scale up," Van Kerkhove added.

Global Covid-19 cases have surpassed 61 million with the death toll topping 1.4 million, according to the latest data from Johns Hopkins University.

"What we don't want to see is situations where you are moving from a so-called lockdown state to bring the virus under control to moving to a so-called lockdown state," she warned.

Facebook 56
blogger sharing button blogger
buffer sharing button buffer
diaspora sharing button diaspora
digg sharing button digg
douban sharing button douban
email sharing button email
evernote sharing button evernote
flipboard sharing button flipboard
pocket sharing button getpocket
github sharing button github
gmail sharing button gmail
googlebookmarks sharing button googlebookmarks
hackernews sharing button hackernews
instapaper sharing button instapaper
line sharing button line
linkedin sharing button linkedin
livejournal sharing button livejournal
mailru sharing button mailru
medium sharing button medium
meneame sharing button meneame
messenger sharing button messenger
odnoklassniki sharing button odnoklassniki
pinterest sharing button pinterest
print sharing button print
qzone sharing button qzone
reddit sharing button reddit
refind sharing button refind
renren sharing button renren
skype sharing button skype
snapchat sharing button snapchat
surfingbird sharing button surfingbird
telegram sharing button telegram
tumblr sharing button tumblr
twitter sharing button twitter
vk sharing button vk
wechat sharing button wechat
weibo sharing button weibo
whatsapp sharing button whatsapp
wordpress sharing button wordpress
xing sharing button xing
yahoomail sharing button yahoomail